Table of Contents
What changed
Revenue rose 14.1% to NZ$173.0m on 692 occupation-right sales (HY24: 588). However, profit before tax fell 9.1% to NZ$109.8m and operating profit slipped 5.2% to NZ$126.6m. Reported NPAT nevertheless climbed 24.5% to NZ$127.2m, and the company-disclosed underlying profit was NZ$106.6m, up 19%. Operating cash flow rose 19.3% to NZ$228.7m, but capex stepped up sharply to NZ$74.5m (HY24: NZ$27.4m), and gross borrowings increased 21.3% to NZ$1.87bn against a cash balance of just NZ$17.7m. The interim dividend was held at 11.3 cents per share.
What matters
- The NPAT/PBT divergence is tax-driven, not operational. HY25 carries a tax credit of roughly 15.8% of PBT, versus a 15.4% tax charge in HY24. Strip that out and the cleaner read is PBT down NZ$11.0m, or 9.1%, on revenue up NZ$21.4m. The reported 24.5% NPAT uplift overstates underlying earnings momentum; management's own underlying profit (+19%) sits between the two.
- Leverage is stepping up while cash is thinning. Net debt rose to roughly NZ$1.85bn from NZ$1.52bn a year earlier, funding a 17.9% expansion in total assets to NZ$8.7bn. Cash fell to NZ$17.7m. For a development-heavy retirement operator this is the shape of the business model, but the direction of travel on gearing is clearly loosening.
- Capex intensity has surged. Payments for property, plant and equipment hit NZ$74.5m (43.1% of revenue) versus NZ$27.4m (18.1%) in HY24, driven by care-centre construction. That investment is what took pre-lease free cash flow down to NZ$154.2m from NZ$164.2m despite stronger operating cash generation.
Expectations
No quantitative earnings guidance or forward-work disclosure is provided in the release excerpts, so forward shape has to be inferred from history. FY24 was heavily second-half weighted: HY24 contributed only 47.4% of FY24 revenue and just 30.1% of FY24 NPAT (the latter skewed by fair-value movements). Annualising HY25 revenue gives NZ$346.1m, about 8.2% above the FY24 base of NZ$319.9m, so the run-rate is ahead of last year but below what a typical 2H-weighted pattern would imply at full year. The release does not disclose any specific FY25 target to test.
Quality of result
Mixed. The volume signal is real — 692 occupation-right sales is a 17.7% lift — and operating cash flow of NZ$228.7m genuinely exceeds reported NPAT. But several quality flags warrant attention. First, reported NPAT is inflated by a tax credit; PBT is the cleaner operating read and it declined. Second, cash conversion softened on a free-cash-flow basis: pre-lease FCF fell NZ$9.9m year on year even as OCF grew NZ$37.1m, because capex more than doubled. Third, underlying profit of NZ$106.6m is disclosed without a full reconciliation to IFRS NPAT of NZ$127.2m in the supplied excerpts, leaving the bridge between reported, underlying and tax-adjusted earnings unclear. Receivable days did improve by roughly 4.8 days, which is a modest working-capital positive.
Unresolved
- What is driving the HY25 tax credit, and is it a one-off deferred-tax recognition or likely to persist?
- What explains the reported fall in operating profit and PBT against a 14.1% revenue lift — is it fair-value movements on investment property, higher interest cost on the expanded borrowings, or both?
- How does the NZ$106.6m underlying profit reconcile line-by-line to IFRS NPAT, and how is development margin trending versus the FY24 28.9% mark?
- What is the committed development pipeline and its funding plan given gross borrowings at NZ$1.87bn and cash at NZ$17.7m?
- Is the interim dividend being held flat because of capex intensity, or as steady-state policy given 1H earnings volatility?
This briefing cannot assess the underlying property fair-value movements, segment-level profitability, or the full reconciliation between IFRS and underlying earnings from the supplied data.
Key metrics
| Metric | HY25 | HY24 | Change |
|---|---|---|---|
| Revenue | $173.0m | $151.6m | +14.1% ↑ |
| Net profit after tax | $127.2m | $102.2m | +24.5% ↑ |
| Net cash inflow from operating activities | $228.7m | $191.6m | +19.3% ↑ |
| Interim dividend per share | 11.3c | 11.3c | flat |
| Cash and cash equivalents | $17.7m | $21.0m | -15.8% ↓ |
| Total assets | $8.7b | $7.4b | +17.9% ↑ |
Analytical metrics
| Metric | HY25 | HY24 | Context |
|---|---|---|---|
| PBT growth | -9.1% | — | cleaner earnings measure |
| Effective tax rate | -15.8% | 15.4% | — |
| FCF pre-lease | $154.2m | $164.2m | −$9.9m |
| FCF / NPAT | 121.3% | 160.7% | complementary conversion metric |
| Capex % revenue | 43.1% | 18.1% | — |
| Capex | −$74.5m | $27.4m | −$101.9m |
| Debtor days | 50.8 | 55.6 | -4.8 days |
| Trade debtors | $48.3m | $46.3m | +$2.0m |
| Net debt | $1.8b | $1.5b | +$330.7m |
| Gross borrowings | $1.9b | $1.5b | +$327.4m |
| Payout ratio vs NPAT | 21.3% | — | — |
| Payout ratio vs FCF pre-lease | 17.5% | — | covered |
| ROE (annualised) | 4.0% | 3.8% | Strengthening |
| HY24 share of FY24 revenue | 47.4% | — | Other half was 52.6% |
| HY24 share of FY24 NPAT | 30.1% | — | Other half was 69.9% |
| Profit from continuing operations | $127.2m | $102.2m | +$25.0m |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.